Artiva Biotherapeutics, Inc. (ARTV) insider trading
Recent insider transactions reported to the SEC on Form 4 — directors and officers buying or selling their own company’s stock. Sourced directly from public SEC filings, latest filed Nov 18, 2026.
- Filings shown
- 58
- Open-market buys
- 21
- Open-market sells
- 26
- Buys, 10b5-1 box not checked
- 21 of 21
Counts cover the 58 most recent Form 4 filings Tradune holds for ARTV (filed May 13 – Nov 18, 2026); the score below covers only the trailing 90 days (0 buys, 20 sells). SEC EDGAR Form 4 filings for ARTV last checked Nov 21, 2026, 09:00 UTC; the latest ARTV filing Tradune holds was filed Nov 18, 2026. This is not guaranteed to be the complete record — see ARTV's full Form 4 filing history on SEC EDGAR.
Open-market activity, last 90 days
Purchases (Form 4 code P) and sales (code S) on the 40 filings Tradune holds for ARTV filed Aug 31 – Nov 18, 2026. Grants, exercises, tax withholding and the other Form 4 transaction codes are left out.
20 open-market sales by Rule 10b5-1 checkbox
- On filings with the 10b5-1 box checked
- 3 sales· 55,114 sh
- checkbox disclosed
- On filings with the box not checked
- 17 sales· 410,014 sh
- not proof that no plan exists
- Not comparable
- 0 sales· 0 sh
- filed before Apr 1, 2023, or no checkbox value in the filing data
Counts are Form 4 lines as filed. The checkbox is one per filing, so every sale on a filing with the box checked is counted there even if only some of its transactions were under a plan; it records what the filer disclosed, and the three categories are not a judgement about why a sale was made.
| Insider | Buys | Sells | Shares bought | Shares sold | Value |
|---|---|---|---|---|---|
| Fred AslanChief Executive Officer | 0 | 6 | — | 352,425 | −$2,265,350 |
| Subhashis BanerjeeChief Medical Officer | 0 | 5 | — | 15,568 | −$138,954 |
| Christopher HoranChief Tech Operations Officer | 0 | 4 | — | 51,675 | −$310,288 |
| Jennifer BushCOO, CLO, Compliance Officer | 0 | 4 | — | 44,417 | −$261,292 |
| Gines Diego MirallesPresident & Head of R&D | 0 | 1 | — | 1,043 | −$4,080 |
Value = shares × the price reported on each Form 4 (+ purchases, − sales); every open-market line in this window disclosed a price.
Insider-activity score
0/ 100
Summarises ~90 days of public SEC Form 4 activity — more distinct buyers, officer involvement and net buying score higher. A description of filing activity, not a rating or buy signal. How this score is computed →
Get alerted when insiders buy the stocks you own
Add your holdings — no brokerage login — and Insider Radar sends a Telegram alert when an open-market Form 4 buy of $100,000 or more is filed on a stock you hold or watch.
Free for everyone right now · no card · nothing to buy
How to read this: an open-market purchase (Form 4 code P) is a buy at the market price with the insider’s own money, as opposed to a grant, award or option exercise; an open-market sale is code S. When two or more distinct insiders report open-market purchases in the same 90-day window, this site labels that a cluster — a definition, not a forecast; see insider cluster buying. “Held after” is Form 4 Table I column 5; “Change” = shares ÷ holdings before the trade (held after − shares for an acquisition, held after + shares for a disposition).
Insider Buying at ARTV
Insiders reported 21 open-market purchases of ARTV between May 13, 2026 and Nov 18, 2026, across 2 distinct buyers. The most recent purchase was reported by Ra Capital Management, L.P. (Director, 10% owner) on Jul 31, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.
Recent Form 4 filings
Source: SEC EDGAR Form 4 · transaction codes explained
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box not checked | 1,043 | $3.91 | 121,457 | −0.9% | Nov 17, 2026 |
† change in this filer’s own reported holding line (Form 4 Table I, col. 5), not of total company ownership; small prior holdings produce large percentages, so under 100 shares the prior holding is shown instead.
“10b5-1 box checked” = the filer checked the Form 4 box stating that a transaction on the filing was made under a plan intended to satisfy Rule 10b5-1(c); “10b5-1 box not checked” = the box was left blank, which does not prove that no plan exists. The box applies to Form 4s filed from April 1, 2023; older filings, and boxes we could not read, carry no tag. What the 10b5-1 box means.
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box not checked | 20,546 | $3.91 | 281,775 | −6.8% | Nov 17, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box not checked | 19,217 | $3.91 | 338,503 | −5.4% | Nov 17, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box not checked | 4,037 | $3.91 | 164,701 | −2.4% | Nov 17, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box not checked | 119,771 | $3.91 | 1,337,657 | −8.2% | Nov 17, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box not checked | 10,423 | $4.18 | 302,321 | −3.3% | Nov 2, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box not checked | 8,439 | $4.18 | 357,720 | −2.3% | Nov 2, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box not checked | 1,110 | $4.18 | 168,738 | −0.7% | Nov 2, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box not checked | 62,178 | $4.18 | 1,457,428 | −4.1% | Nov 2, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box checked | 23,463 | $7.20 | 1,519,606 | −1.5% | Oct 6, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box not checked | 10,340 | $6.84 | 312,744 | −3.2% | Oct 5, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box not checked | 8,370 | $6.84 | 366,159 | −2.2% | Oct 5, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box not checked | 1,099 | $6.84 | 169,848 | −0.6% | Oct 5, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Open-market sale 10b5-1 box not checked | 61,696 | $6.84 | 1,543,069 | −3.8% | Oct 5, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award | 110,000 | — | 1,604,765 | +7.4% | Sep 15, 2026 |
| Grant / award Employee Stock Option (Right to Buy) | 315,000 | — | — | — | Sep 15, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Director Stock Option (Right to Buy) | 16,250 | — | — | — | Sep 10, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award | 45,000 | — | 1,494,765 | +3.1% | Sep 10, 2026 |
| Grant / award Employee Stock Option (Right to Buy) | 155,000 | — | — | — | Sep 10, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Director Stock Option (Right to Buy) | 16,250 | — | — | — | Sep 10, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Director Stock Option (Right to Buy) | 16,250 | — | — | — | Sep 10, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Director Stock Option (Right to Buy) | 16,250 | — | — | — | Sep 10, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Director Stock Option (Right to Buy) | 16,250 | — | — | — | Sep 10, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Director Stock Option (Right to Buy) | 16,250 | — | — | — | Sep 10, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award Director Stock Option (Right to Buy) | 16,250 | — | — | — | Sep 10, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award | 45,000 | — | 122,500 | +58% | Sep 9, 2026 |
| Grant / award Employee Stock Option (Right to Buy) | 135,000 | — | — | — | Sep 9, 2026 |
| Transaction | Shares | Price | Held after | Change† | Date |
|---|---|---|---|---|---|
| Grant / award | 40,000 | — | 323,084 | +14% | Sep 9, 2026 |
| Grant / award Employee Stock Option (Right to Buy) | 120,000 | — | — | — | Sep 9, 2026 |
Listing the 25 most recent of 58 Form 4 filings held for ARTV; the 33 older filings (filed May 13 – Sep 11, 2026) are counted above but not listed here — see ARTV's full Form 4 filing history on SEC EDGAR.
Insider filings reported around the same time
Other companies whose most recent Form 4 was filed closest to ARTV's (Nov 18, 2026).
Frequently asked about ARTV insider activity
How many insiders bought ARTV stock in these Form 4 filings?
2 distinct insiders at Artiva Biotherapeutics, Inc. reported 21 open-market purchases (Form 4 code P) of ARTV shares between May 13, 2026 and Nov 18, 2026, the most recent filed by Ra Capital Management, L.P. (Director, 10% owner) on Jul 31, 2026. Grants, option exercises, and tax-withholding transactions are excluded from these counts.
Who filed the most recent Form 4 for ARTV?
The most recent Form 4 on this page was filed by Fred Aslan (Chief Executive Officer) on Nov 18, 2026, reporting 1 transaction. The original document is linked from the filing list above on SEC EDGAR. Amended filings (Form 4/A) may later revise reported figures.
What was the largest open-market ARTV insider purchase shown?
The largest open-market purchase among the filings shown was 6,510,416 ARTV shares at $11.52 (about $74,999,992) by Ra Capital Management, L.P. (Director, 10% owner) on May 11, 2026. Value is shares × the price reported on the Form 4; its Rule 10b5-1 box is not checked.
Do the recent ARTV insider purchases have the Form 4 10b5-1 box checked?
No. All 21 ARTV open-market purchases shown were reported with the Rule 10b5-1 box not checked. A blank box records what the filer disclosed; it does not prove that no plan exists. Latest: Ra Capital Management, L.P. (Director, 10% owner) on Jul 31, 2026, 24,944 shares.
New to Form 4s? The transaction codes, the 90-day window and the 0–100 score are defined on the insider-activity score methodology page.
Get insider alerts for ARTV — and your whole portfolio
Tradune watches SEC Form 4 filings and flags insider-cluster buying across everything you hold, routed to you automatically. Free for everyone right now · no card · nothing to buy
This score summarizes SEC Form 4 filing activity over the trailing 90 days. It is descriptive, not predictive — not a rating, recommendation, or investment advice. Data: SEC EDGAR (public domain), as filed; amendments may revise figures. Tradune is not a registered investment adviser.
Data as filed; amended filings (Form 4/A) may revise figures. Sales may occur under prearranged Rule 10b5-1 trading plans.